palladium has been researched along with gemcitabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nori, D; Parikh, S | 1 |
| Bradley, M; Carragher, NO; Dawson, JC; Fraser, C; Patton, EE; Rybski, W; Torres-Sánchez, C; Unciti-Broceta, A; Weiss, JT | 1 |
2 other study(ies) available for palladium and gemcitabine
| Article | Year |
|---|---|
Unresectable pancreatic adenocarcinoma treated with palladium-103 implant and chemoradiation.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy, Needle; Brachytherapy; Deoxycytidine; Fatal Outcome; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Palladium; Pancreatic Neoplasms; Radioisotopes; Radiotherapy, Adjuvant; Tomography, X-Ray Computed | 1998 |
Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine.
Topics: Animals; Antimetabolites, Antineoplastic; Carbamates; Cell Line, Tumor; Cell Survival; Deoxycytidine; DNA Damage; Drug Carriers; Drug Screening Assays, Antitumor; Embryo, Nonmammalian; Gemcitabine; Humans; Nanoparticles; Palladium; Polystyrenes; Prodrugs; Rhodamines; Structure-Activity Relationship; Zebrafish | 2014 |